New Clinical Indication

VolumeRad Tomosynthesis

New Clinical Indication

VolumeRad Tomosynthesis

VolumeRAD significantly increases detection sensitivity, enabling the radiologist to confidently detect more lung nodules than 2-view chest X-ray (CXR).

Related Content

  • Radiography On-label Publication List

    Download
  • VolumeRAD Tomosynthesis Technology From GE Healthcare Now Supports Lung Nodule Detection

    Download
  • VolumeRAD Tomosynthesis Brochure

    Download
*No clinical evidence has been established supporting the following claims in patients with active lung or pleural disease that could obscure pulmonary nodules, including fibrosis, emphysema, compressed lung, scarring, severe lung disease, and in patients with objects in or around the lungs that could obscure pulmonary nodules. The effectiveness of the device may vary depending on nodule prevalence and type.